Bridgeway Capital Management’s Allied Healthcare Products AHPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-36,000
Closed -$424K 1376
2020
Q2
$424K Sell
36,000
-24,481
-40% -$291K 0.01% 907
2020
Q1
$1.06M Sell
60,481
-6,000
-9% -$46.7K 0.02% 544
2019
Q4
$80K Hold
66,481
﹤0.01% 1261
2019
Q3
$93K Hold
66,481
﹤0.01% 1249
2019
Q2
$124K Hold
66,481
﹤0.01% 1229
2019
Q1
$121K Hold
66,481
﹤0.01% 1267
2018
Q4
$133K Hold
66,481
﹤0.01% 1268
2018
Q3
$146K Hold
66,481
﹤0.01% 1354
2018
Q2
$161K Buy
66,481
+19,681
+42% +$50.2K ﹤0.01% 1329
2018
Q1
$133K Buy
+46,800
New +$122K ﹤0.01% 1306

Other funds holding AHPI

Bridgeway Capital Management's AHPI Position: Q3 2020 in Review

Bridgeway Capital Management sold out of Allied Healthcare Products (AHPI) in Q3 2020, closing a stake of 36,000 shares — an estimated $424K sold.

Bridgeway Capital Management first reported a position in AHPI in Q1 2018 and held it in 10 quarters. The position peaked at $1.06M in Q1 2020. 18 funds tracked by Wall St. Rank hold AHPI as of Q3 2020.

  • Bridgeway Capital Management reported no remaining Allied Healthcare Products position as of Q3 2020 after selling out during the quarter.
  • Bridgeway Capital Management sold 36,000 Allied Healthcare Products shares in Q3 2020, an estimated $424K.
  • Bridgeway Capital Management first reported a position in Allied Healthcare Products in Q1 2018 and held it in 10 quarters.
  • Bridgeway Capital Management's Allied Healthcare Products position peaked at $1.06M in Q1 2020.
  • 18 funds tracked by Wall St. Rank held Allied Healthcare Products as of Q3 2020.

Based on Bridgeway Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.